Though the use of thyroid hormone in the treatment of hypercholesterolemia in the humans received wide acceptance, its practical use is limited by the high incidence of angina attack and by the influence through the augmented rate of basal metabolism. 3,5,3'-Triiodothyronine (T3), 3,5,3'-triiodothyroacetic acid (Triac), 3,5,3'5'-tetraiodothyro acetic acid (Tetrac) and other possible metabolites of thyroxine were reported to sup press serum cholesterol levels within the range of doses which did not produce con comitant rise in basal metabolic rate (1-4). Through these experiments the evaluation of other derivatives became one of the most attractive projects not only for the clinical but also the experimental studies for attempting to separate the cholesterolytic property from the effect on the basal metabolism by changing the chemical structures. Among them, 3,5,3'-triiodothyroformic acid (T3-F) was reported by Boyd and Oliver (3, 4) as a possible metabolite of thyroxine. Kumaoka et al. (5) demonstrated that 3,5,3'-triiodo-4' acetyl-thyroformic acid (TBF-43) produced a moderate cholesterolytic effect without much increase of basal metabolic rate in cases of essential hypertension and myxedema when 10 to 50 mg were prescribed daily. Acute and subacute toxicities of the compound were presented by Aramaki et al. (6) and Kajihara et al. (7). They reported that sub acute oral administration of TBF-43 in the daily doses above 40 mg/kg caused a retarda tion of growth in rats. Furthermore, the autopsy study proved an increase in the weight of the parenchymal organs, especially the heart, kidney and adrenal gland.
standard diet was previously described (8) . The animals were kept in individual cages. The powdered diet was admitted to the diet container about 80 ml in volume, and the dispersion of the powdered food was prevented by covering with a plastic plate with several holes through which animals were allowed to pick up the food. In the experi ments of the rats fed on high-cholesterol diet, the standard diet was added with 5% of hardened oil (ECONA oil, Kao-sekken Co.), 1 % of cholesterol and 0.5% of taurocholic acid.
2) Rabbits: Male albino rabbits weighing about 2.0 kg at the beginning of the ex periments were fed on the standard compressed diet (RC-5) of Oriental Kobo-kogyo Co., and water in an air-conditioned room at temperature of 22±1°C. The composi tion of the standard diet was described previously (8) . The preliminary experiments showed that each rabbit given water ad libitum took up at least 80 g/day/animal of the diet. The high-cholesterol diet for the rabbits consisted of 80 g/day/animal of the standard diet added with 1% cholesterol and 10% of soya bean oil.
Administration of TBF'--43 1) Rats: Since it was reported that the daily dose for the cholesterolytic use of TBF-43 is about 1 mg/kg/day (5), the daily doses of 5, 10, 30 and 100 mg/kg of TBF-43 were mixed into the powdered standard diet for 12 weeks. In another series of experi ment, 1, 3 and 5 mg/kg/day of the compound were orally administered for 48 weeks. Further, the doses of 5 mg/kg/day of TBF-43 and of 5 4ag/kg/day of T, were also given to the rats fed on the high-cholesterol diet for 16 weeks.
2) Rabbits: In the rabbits fed on the high-cholesterol diet for 12 weeks the daily doses of 5, 15 and 30 mg/kg of TBF-43 were added into the diet. No animal refused to take the diet mixed with the compound.
Measurements
Details of the measurements were previously described (8) . The body weight of the animals was measured once a week over a period of the experiments. In the rats, the food was supplied three times a week and the amounts of the food/week/animal were calculated from the measurement of the residual food. During and after the term of the drug administration, five to ten rats were sacrificed at random for the pathological examinations and for the measurement of the total cholesterol level in the serum and liver and of the level of lipid in the liver. In the rabbits the heart rate and serum cholesterol level were measured every other week. The determinations of total chole sterol concentration in the serum and liver was followed to ferric chloride method devised by Zak (9) and Henley (10) .
Pathological examinations
The animals were sacrificed by decapitation. The . lung, heart, liver, spleen, kidney, adrenal gland, thyroid gland, prostate, hypophysis and testis were separately weighed and were histologically studied by staining with hematoxylin-eosin and with lipotro phic dyes. Three animals in each group were used for the microscopical examinations. In this group one rat died at the 6th week and two rats at the 8th week.
The body weight did not increase in the rats received the daily dose of 100 mg/kg of TBF-43 from the 3rd week. Five animals died at the 3rd week, two at the 4th week, two at the 6th week and one at the 7th week, even though the daily total food consumption was larger than that of the controls.
b) The behaviors and other symptoms There were no differences in the behaviors and general symptoms between the rats which received the daily doses of 5 and 10 mg/kg of TBF-43 and the control animals. The animals at the dose of 30 mg/kg/day showed the sign of depilation, hyperemia of the conjunctiva, rhinorrhea and lacrimation after the 3rd week. The spontaneous move ments were decreased. These symptoms were more markedly observed in the animals which died during the experimental period. The depilation was so marked at the 100 mg/kg/day level that the scalp, face and abdomen were covered only with short downy hair. The marked increase of the salivary secretion, conjunctivitis, hemorrhage in the paws, tachypnea and tachycardia were developed. In spite of the manifestation of ataxia before death, the animals took up the increased amounts of food.
There was no observable abnormality in the male rats received the daily doses of 1, 3 and 5 mg/kg of TBF-43 for 48 weeks, not only of the growth rate but also of the general symptoms and behaviors. 2) Food consumption The amount of food consumption in grams/rat/day for 12 week is illustrated in Fig. 2 . There was no significant difference between the rats which received the daily dose of 5 mg/kg of the compound and the control rats. However, a definite increase of 1 to 2 g/rat/day was observed in the rats at the doses of 10 and 30 mg/kg/day. Much larger amounts of food were taken up by the rats which received the daily dose of 100 mg/kg of TBF-43. , Therefore, it was necessary to adjust the mixing rate of TBF-43 in the food at least once a week in order to maintain the predetermined oral doses exactly. However, the average daily food con sumption in the rats by the oral administration of 1, 3 and 5 mg/kg/day of T}3F-43 was not significantly different during 48-week experimental period from that in the control rats fed on the standard diet alone. 2. Experiments in rats fed on high-cholesterol diet 1) Body weight and food consumption The high-cholesterol diet containing 5% of hardened oil, 1 % of cholesterol and 0.5% of taurocholic acid was fed to 70 young male rats for 4 weeks. Ten rats were sacrificed at random for the determination of cholesterol concentrations in the serum and liver. The remaining 60 animals were subdivided into three groups, each consisted of 20 rats. One group was allowed to receive further the high-cholesterol diet, and was used as a control. Another two groups received the same diet supplemented with 5 mg/kg/day of TBF-43 and 5 pg/kg/day of 3,5,3'-triiodothyronine (T3), respectively. At the end of the 4th, 8th and 12th weeks of the drug administration five rats from the control and treated groups were sampled at random for sacrifice. The addition of cholesterol and taurocholic acid to the diet was stopped at the end of the 16th week of the cholesterol feeding, and the remaining five rats in each group were fed on the standard diet added with 5% of hardened oil alone for another 4 weeks. Even during these regimes, the same doses of TBF-43 and T3 was administered further in the treated groups. The growth and food consumption of the control and treated animals are presented in Table 1 . The rise of body weight in the cholesterol-fed rats which received the daily dose of 5 ttg/kg of T3 was slightly lesser after the 5th week of the drug administration than those of the control rats fed on the high-cholesterol diet alone. However, there was no difference in the body weight gain between in the rats which were fed on cholesterol diet with the daily dose of 5 mg/kg of TBF-43 and in the control animals.
Average daily food consumption for rats received TBF-43 or T3 was not significantly different from that of the control rats. The similar conclusion was presented by the determination of the amounts of food/100 g body weight/day . In addition, the animals which received the high-cholesterol diet supplemented with TBF-43 or T 3 did not show any abnormality of the general symptoms. 2) Total cholesterol level in serum
As was reported previously (8) , the feeding of the rats on the high-cholesterol diet supplemented with taurocholic acid increased the level of total cholesterol in the serum .
The peak effect was usually observed at the 8th week of the cholesterol-feeding . There after, the level of cholesterol declined spontaneously despite the further cholesterol-feed ing. The withdrawal of cholesterol and taurocholic acid from the high-cholesterol diet at the end of 16th week and further feeding of the animals on the diet containing hardened oil alone resulted in the progressive reduction of the cholesterol level in every groups of animals.
3) Total cholesterol and lipid levels in liver It was previously reported that the feeding of the rats on the high-cholesterol diet increased the level of total cholesterol in the liver to 38.80 mg/g wet tissue weight, which was about 8 times higher than that before the cholesterol-feeding, at the 4th week (8) . The level, however, decreased spontaneously and progressively despite the fur ther feeding of the animals on the same diet.
As showh in middle column of Table 2 On the other hand, the administration of 15 and 30 mg/kg/day of the compound caused a marked increase in the heart rate from the 4th week, and the average heart rate was in the range of 320 to 345/min.
These results are shown in Fig. 4 .
2) Total cholesterol level in serum
The level of total cholesterol in the serum of the rabbits was markedly and progressively increased along with the length of the cholesterol-feeding, as was reported previously (8) . No spontaneous decline of the cholesterol level was observed in the rabbits.
The daily oral administration of 5, 15 and 30 mg/kg of TBF-43 failed to prevent the increase of the total cholesterol level in the serum, as shown in Table 3 . Moreover, Table 4 . 4. Autopsy and histopathology 1) Rats received 5, 10, 30 and 100 mg/kg/day of TBF-43 for 12 weeks Autopsy were performed on all the rats which died during the course of the study .
At the end of 12th week, the surviving control and treated rats were sacrificed . Autopsies and microscopic examinations of the representative tissue specimens were performed . Table 5 summarized the mean wet weight of the various tissues such as heart , lung, liver, spleen, kidney, adrenal gland, thyroid gland , hypophysis and testis in the control and treated animals in reference to the tissue weight per body weight (100 g).
The tissue weight per body weight of lung and left kidney in the rats which received 5 mg/kg/day of TBF-43 were significantly (P<0.01) larger than those of the controls. In only one among three rats at the dose of 5 mg/kg/day, the thyroid gland showed slight atrophic changes of the follicular epithelia.
Other tissues in the animals received 5 mg/kg/day of TBF-43 failed to show any remarkable alterations which might be at tributed to the thyrotrophic activity of the compound.
In the rats received the daily dose of 10 mg/kg of TBF-43, the heart, spleen and kidney showed a significant increase in weight at P<0.01. were not uniform in degree.
In one rat, the content of colloid substances in the follicles of thyroid gland was decreased, and the number of mature sperma cells in the testis was slightly reduced.
In the rats received the daily dose of 30 mg/kg of TBF-43, the significant increase in the tissue weight was observed in the heart, spleen and kidney, while the signi ficant decrease was noted in the thyroid gland, hypophysis and right testis at P< 0.01. Since the animals showed a marked retardation of the body weight gains during 12 weeks of the drug administration, the increase in tissue weight of the heart, lung, spleen, kidney and testis was more clearly demonstrated by expressing the tissue weight per body weight (Table 5 ). Com pared with the control animals the treated rats showed a marked reduction of the fatty tissues in the vicinity of parenchymal organs. In the microscopic examinations , the rats at the 30 mg/kg/day level showed atrophic pictures of the peribronchial lymph glands, the central portion of the hepatic lobules and the white pulp of the spleen. In two among three rats , there were slight hyaline and hypertrophic degenerations in the capillary epithelia of the glomerulus and in the epithelia of the proximal tubules of the kidney . The hyaline casts were also detected in the tubular canals of the renal cortex in one animal . The marked flatten ing of the follicular epithelia in the thyroid gland was attributable to the progressive atrophy. In one rat, there were considerable infiltrations of plasma cells and lympho cytes in the interstitial tissues of the thyroid gland . The marked increase of the tissues weight per body weight in the rats received the daily dose of 100 mg/kg of TBF-43 was partly derived from the extreme deprivation of the body weight. The increase in weight of the liver , heart, kidney and adrenal gland of the dead animals from the 4th to 7th week were 2.5, 2.8, 3.4 and 3.9 times of the control weight by expressing the tissue weight per body weight , respectively. The macroscopical observation proved the marked reduction of the fatty tissues . In the rats at the dose of 100 mg/kg/day for 4 to 7 weeks, the moderate congestion of the lung were accompanied with marked atrophic changes of the peribronchial lymph glands . The congestion and central atrophy of the hepatic lobules were also observed . In the spleen the disappearance of the central structure and outer band of the white pulp was a strong indication for the atrophic changes . The scattered lesions of the degeneration of the neutrophilic cells were detected in the spleen of one animal . The capillary epi thelia of the renal glomerulus showed hypertrophic changes and deposit of hyaline sub stances accompanied with compensatory dilatation of the adjacent tubular canals . These pictures were an indication for the regenerative process of glomerular structures. The degenerative changes in the epithelia of the proximal and distal tubules were also ob served. The adrenal gland showed an atrophic picture revealing the reduction of the lipoid contents and the disappearance of the zonular structures . The thyroid gland showed a marked atrophy exhibiting the extreme reduction of the number of follicles , the marked flattening of the epithelial cells, the reduction of the colloid substances and the proliferation of the interstitial tissues . The number of mature sperma cell in the testis was also reduced.
2) Rats received 1, 3 and 5 mg/kg/day of TBF-43 for 48 weeks
At the ends of the 24th, 36th and 48th weeks of the oral administration of 1 , 3 and 5 mg/kg/day of TBF-43, the control and treated rats were sacrificed for autopsies . Table  6 summarized the mean wet weight of the tissues such as heart , lung, liver, spleen, kidney, adrenal gland, thyroid gland, prostate and testis . The weight of the adrenal gland of the rats which received 5 mg/kg/day of TBF-43 for 36 weeks were significantly (P<0.05) larger than that of the respective control. There was slight but insignificant increase in the weight of lung in the rats at the dose of 5 mg/kg/day for 24 , 36 and 48 weeks as compared to the corresponding controls .
Histological examinations of the tissues in the rats received the daily dose of 1 The oral administration of 5 mg/kg/day of TBF-43 for 4 weeks caused slight im provement of the pathological changes induced by the cholesterol-feeding. Especially, the picture of fatty degeneration in the liver was ameliorated.
No abnormality was observed in the thyroid gland. However, the increased manifestation of the vacuoles and disorganization of the zonular structures in the adrenal gland were still detected.
On the other hand, the administration of 5,ag/kg/day of T3 for 4 weeks failed to im prove the pathological abnormalities caused by the cholesterol-feeding. The fatty degeneration of the hepatic cell and the atrophy of follicular epithelia in the thyroid gland were observed. Moreover, the vacuoles in the adrenal gland were increased in number and the disorganization of the zonular structures was also observed .
The pathological signs of the tissues, especially of the liver , improved spontaneously despite the continued feeding of the rats on cholesterol and taurocholic acid . The fatty degeneration of the liver in the rats fed on the high-cholesterol diet for 12 weeks was reduced in degree. However, the atrophic and degenerative changes of the follicular epithelia were observed in some portion of the thyroid gland . 
4) Effects of TBF-43 on the rabbits fed on high cholesterol diet
There were marked proliferations of the sub cutaneous and retroperitoneal fatty tissues in the rabbits fed on the high-cholesterol diet for 16 weeks.
The liver showed a yellow-brown discoloration and the adrenal gland showed a light yellow discolora tion. In the cholesterol-fed rabbits which received the daily dose of 5 mg/kg of TBF-43 for 12 weeks, the subcutaneous and retroperitoneal fatty tissues were reduced. Furthermore, the fatty tissues almost dis appeared in the animals received the daily dose of 15 and 30 mg/kg of the compound.
Even in these animals the discoloration of the liver and adrenal gland was observed. Table 7 summarized the mean wet weight of the tissues such as heart, lung, liver, kidney, adrenal gland, thyroid gland and testis. Though slight decrease in weight was observed in the lung, liver, adrenal gland and thyroid gland of the rabbits received 5 mg/kg/day of TBF-43, these increases were insignificant. In the rabbits received the daily dose of 15 mg/kg of the compound, the weight of the liver, thyroid gland and testis showed some decrease, while the weight of the lung, spleen, kidney and adrenal gland increased slightly despite the reduction of the body weight. Marked decrease in the weight was observed in the liver, thyroid gland and testis of the rabbits which received the daily dose of 30 mg/kg of TBF-43. Since the administration of TBF-43 reduced the body weight, the tissue weight per body weight was generally increased, particularly in the heart, lung, kidney and adrenal gland. Deposit of fats in the various tissues was markedly increased in tthe rabbits fed on the high-cholesterol diet for 16 weeks. The heart tissue showed signs of some con gestion, and in one animal there were hyaline degeneration of the muscle and prolifera tion of the connective tissues. In all cholesterol fed rabbits, the large and intermediate In one out of three animals, extreme hypertrophy of the endothelium resulted in a stenosis of the aortic space. The diffuse lobular fatty infiltration in the liver of the rabbits received 5 mg/kg/day of TBF-43 was more marked than that of the untreated animals.
The fatty infiltration was observed even in the peripheral part of the hepatic lobules.
In the adrenal gland the gross vacuoles were detected in the glomerular zone, inner layer of the fascicular zone and small vacuoles in the reticular zone. The border be 'tween the glomerular and fascicular zones was vague in one animal.
The size of the follicles of thyroid gland was not uniform and the shape of the follicular epithelia were polymorphous. Moreover, the flattening of the epithelia and the uneven coloration of the intrafollicular colloid were indicative for the atrophy of the thyroid structures.
The reduction of number of the sperma cells was observed in the testis.
In general, the pathological changes of the tissues mentioned above were more marked in the rabbits which received the daily dose of 15 mg/kg of TBF-43. There was hyaline hypertrophy of the intima of the arteries and arterioles in the brain paren chyma. The hyaline hypertrophy of the intima and the obstructive changes in the coronary arteries resulted in the proliferation of the interstitial tissues and the fatty degeneration of the heart muscle. One animal showed many regions of the bionecrosis indicative for the manifestation of the heart infarct. In the lung, the atheromatous hypertrophy of the intima and media caused the arterial and arteriolar stenosis. The similar hypertrophy was also observed in the large arteries of the lung. The more marked pathological changes were detected in rabbits received the daily dose of 30 mg/kg of TBF-43. The edema and hypertrophy of the intima of the brain arteries were more marked than those in the animals at the 15 mg/kg/day level. Es pecially, in the rabbit died at the 6th week of the drug administration the obstruction of the arteries and arterioles due to the hypertrophy of the intima was observed in the brain and heart. The pathological pictures in the lung, aorta and liver of the rabbits received 30 mg/kg/day of the compound were almost the same as those in the animals at the 15 mg/kg/day level. The glomerular zone of the adrenal gland showed a marked hypertrophy and the extent of the zone was 2 to 3 times of that in the un treated animals. On the other hand, the fascicular zone was narrow in width and contained many gross vacuoles. The pathological changes of the thyroid gland and testis were similar to those in the glands of the rabbits which received 15 mg/kg/day of TBF-43.
DISCUSSION
Though the cholesterolytic effect of thyroid hormone in the experimental animals and humans has generally been accepted, the mode of action remains to be settled. In an attempt to separate the cholesterolytic effect from the basal metabolic one, various iodothyroalkyl acids were extensively subjected to experimental and clinical trials. 3,5,3'-Triiodo-4'-acetyl-thyroformic acid (TBF-43) was reported to exhibit a considerably strong cholesterolytic effect with little increase in the basal metabolic rate in the hyper cholesterolemic patients (5) . The acute and subacute toxicity of the compound in the mice and rats showed that the margin of safety for the cholesterolytic effect was relatively narrow (6, 7) .
The chronic toxicity of TBF-43 in the rats and rabbits fed on the standard diet or the high-cholesterol diet was described in the present report. The daily administra tion of the compound above the dose of 30 mg/kg caused a significant depression on the body weight gains in the rats fed on the standard diet. Moreover, the animals treated with TBF-43 took up larger amount of food compared with controls. The increased uptake of the food was always observed in the rats received the daily dose above 10 mg/kg. The rats which received the daily dose of 30 mg/kg or more showed a sign of depilation and inflammatory change of the mucous membranes. In the rats fed on the high-cholesterol diet the daily administration of 5 mg/kg of TBF-43 did not affect the body weight gains and the food consumption. On the other hand, the same proce dure of 5 ug/kg of 3,5,3'-triiodothyronine (T3) depressed the body weight gains slightly. It was reported that the clinical cholesterolytic doses of TBF-43 and T3 were 1 mg/kg/ day and 1 ,ag/kg/day, respectively (4, 5) . Therefore, the results obtained in the present experiments showed that the depressive effect of TBF-43 on the body weight gain in the rats is weaker than that of T3.
The feeding of the rats on the high-cholesterol diet for 8 weeks elevated consider ably the cholesterol level in the serum and liver, thereafter the increased level declined spontaneously in spite of the continuation of the cholesterol-feeding. The daily admi nistration of 5 mg/kg of TBF-43 or of 5 lug/kg of T3 depressed slightly the elevation of the cholesterol level in the serum induced by the cholesterol-feeding. The spontaneous decline of the serum cholesterol level was also accelerated by both compounds. The more pronouced decrease of the cholesterol level was obtained by the withdrawal of cholesterol and taurocholic acid from the diet. In the liver, the daily administration of TBF-43 did not modify the spontaneous decline of the level during the term of cholesterol-feeding. On the other hand, the daily administration of T3 caused a marked increase in the accumulation of cholesterol in the liver and failed to show the spontane ous decline of the liver cholesterol level during the extended feeding of the animals on the high-cholesterol diet. These results indicate that the cholesterolytic effect of T3 in the liver is relatively weaker than that of TBF-43.
In the rabbits fed on the high-cholesterol diet, the daily administration of TBF-43 depressed the body weight gains and the larger doses of the compound produced a marked emaciation. The rabbits which received the daily dose above 15 mg/kg showed an increase in the heart rate. Moreover, some rabbits at the doses of 15 and 30 mg/ kg/day exhibited a marked degree of emaciation and icterus, and died. These toxic symptoms are likely to derive from the elevation of the basal metabolic rate and the atrophic and degenerative changes of the parenchymatous organs and the arteries. These symptoms were observed more markedly in the rabbits than in the rats. It was pre viously reported (8) These effects of the compound were proportional in intensity to the dose administered.
Therefore, it is concluded that the effects of TBF-43 are much different between rats and rabbits.
The leading role of rabbits as experimental animal for the research of athero sclerosis was emphasized by Mann (11) and Davidson (12) . The results obtained in the present report show clearly that the rats can excessively metabolize the administered cholesterol in some different pathway from the rabbits in order to maintain the normal cholesterol level in the blood and liver. It is assumed that regulating mechanism in the rats is reflected in the spontaneous decline of the cholesterol level which developed gradually after the manifestation of the peak of cholesterol level. It is considered that the rabbits lack the regulating mechanism and show a progres sive elevation of cholesterol level in the serum and liver along with length of the cholesterol-feeding.
The administration of TBF-43 resulted in the accelerating mani festation of the atheromatous hypertrophy of the intima and media of arteries and of the atrophic-degenerative changes of the parenchymatous organs in the rabbits. These effects of TBF-43 are assumed to relate with the lack of regulating mechanism against the elevated cholesterol level in the rabbits. The comparative study of TBF-43 and T3
on the experimental arteriosclerosis in rabbits will be described by Osumi (13) else where.
SUMMARY
The chronic oral toxicity of 3,5,3'-triiodo-4'-acetyl-thyroformic acid (TBF-43) in the rats and rabbits fed on standard diet and high-cholesterol diet was described in the present report. In the rats fed on the standard diet, the daily administration of TBF-43 above the dose of 10 mg/kg resulted in toxic pictures of some parenchymatous organs. The cho lesterolytic effects of the compound differed markedly between rats and rabbits. In the rats, TBF-43 showed preventing effects on the elevation of the cholesterol level in serum and liver and the improving effects on the atrophic-degenerative changes of the parenchymatous organs produced by the cholesterol-feeding. In the rabbits, however, the -compound did not show the improving effects on the, cholesterol level in serum and on the pathological changes of the arteries and parenchymatous organs caused by the cholesterol-feeding. These results are assumed to relate with the differential meta bolic pathway of cholesterol between both species.
